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Background: There is ongoing controversy regarding the validity of controlled diagnos-
tic blocks due to variability in sensitivity, specificity, and accuracy. Consequently, identifica-
tion of false-positive rates, false-negative rates, and placebo responses is crucial. The reasons 
described for false-positive responses to diagnostic anesthetic blocks are many; however, se-
dation and psychological factors have been implied as causes. Further, there is no consensus 
with regards to sedation prior to controlled diagnostic blocks and their influence on the ac-
curacy and validity of a diagnosis.
Study Design: A systematic review of the literature evaluating the influence of sedation on 
diagnostic spinal interventional techniques.
Objectives: To systematically assess the quality of clinical studies evaluating the diagnostic 
accuracy of controlled diagnostic blocks in the diagnosis of chronic spinal pain.
Methods: A comprehensive evaluation of the literature relating to sedation in diagnostic in-
terventional techniques was performed. The methodologic quality assessment of the studies 
was carried out by utilizing Agency for Healthcare Research and Quality (AHRQ) methodo-
logic quality criteria with scores of 50 or higher included in the assessment of the level of evi-
dence. Level of evidence was based on the U.S. Preventive Services Task Force (USPSTF) crite-
ria for the assessment of accuracy of diagnostic studies.
Limitations: All 3 of the studies were produced by one group of authors. Thus paucity of 
the literature on the subject of facet joint pain and the lack of literature on the subjects of dis-
cogenic pain and sacroiliac joint pain are major limitations. 
Results: Three studies were identified which met inclusion and methodologic assessment 
quality criteria. Sedation can be a confounding factor in a small population of patients specifi-
cally if fentanyl is employed and non-stringent criteria are followed. Based on the 3 random-
ized double-blind trials with stringent criteria utilizing 80% pain relief and the ability to per-
form prior painful movements without any significant pain following the diagnostic injection 
in evaluation of facet joint pain, the indicated evidence is Level II-1.
Conclusion: This systematic review provides no significant evidence of the influence of se-
dation either with midazolam or fentanyl in the evaluation of cervical and lumbar facet joint 
pain with controlled cervical and lumbar facet joint nerve blocks with an indicated evidence 
of Level II-1, with application of stringent criteria of at least 80% pain relief and the ability to 
perform previously painful movements after the diagnostic blocks. 
Key words: Sedation, chronic spinal pain, anxiolytics, analgesics, controlled diagnostic 
nerve blocks, opioids, benzodiazepines, zygapophysial or facet joint blocks, provocation dis-
cography, sacroiliac joint injections
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targeted (44-46). False-positive responses may also be 
due to the psychological status of the patient and the 
effects of various drugs have been suggested to affect 
false-positive rates by interfering with the interpre-
tation of the analgesic response to controlled diag-
nostic blocks. Further, psychological variables such as 
depression, anxiety, and excessive somatic symptoms 
are recognized as actively contributing to a patient’s 
perception of pain (47-52). In addition, a diagnosis of 
depression correlates with increased pain (53-55) and 
anxiety decreases a patient’s pain threshold and toler-
ance (56). In samples evaluating chronic pain patients, 
rates of current major depression and anxiety ranged 
from 15% to 59%, significantly higher than the rate 
of 5% to 10% in persons without pain found in the 
general population (57-63).
Consequently, there is ongoing controversy re-
garding the validity of controlled diagnostic blocks. 
Carragee et al (64-67), and others (44-46,68) have 
raised numerous questions about the value of con-
trolled diagnostic blocks. Cohen and Raja (44) de-
scribed that both opioids and sedatives, such as 
midazolam, can lead to false-positive responses by 
producing general analgesia and/or muscle relaxing-
properties that interfere with analgesic responses of 
controlled diagnostic blocks. However, Manchikanti 
et al (11,69,70) showed that psychological factors may 
not have significant influence on the diagnostic va-
lidity of interventional techniques in discogenic and 
facet joint pain. Manchikanti et al (71-74) have also 
shown that midazolam sedation exerts only a minimal 
effect on the diagnostic accuracy of controlled blocks 
of the cervical and lumbar facet joints in the diagnosis 
of facet joint pain. In addition, Manchikanti et al (75) 
have also demonstrated that prior exposure to opioids 
has no significant effect on the diagnostic validity of 
controlled comparative local anesthetic blocks in the 
diagnosis of chronic pain of spinal origin.
Consequently, the issue of providing procedural 
sedation in interventional pain management specifi-
cally for diagnostic techniques remains controversial. 
Further, there is no consensus with regards to seda-
tion prior to controlled diagnostic blocks and the in-
fluence of sedation on the accuracy and validity of the 
diagnosis. 
This systematic review was undertaken to review 
the literature to arrive at appropriate recommenda-
tions for utilization of sedation for controlled diag-
nostic blocks in evaluation of chronic spinal pain.
E volution and phenomenal growth of interventional pain management (IPM) (1-5) has led almost all interventional pain 
physicians to encounter patients with chronic, 
persistent spinal pain with psychological problems 
who also have been exposed to opioids (6-11). 
Among chronic pain disorders, pain arising from 
various structures of the spine constitutes the 
majority of the problems (6). However, due to 
the inability of physical examination, clinical 
symptoms, radiologic evaluation, and nerve 
conduction studies to provide a reliable diagnosis 
of the structural origin of pain in a patient with 
chronic pain without disc herniation and radiculitis, 
controlled diagnostic blocks are considered the 
only means of reliable diagnosis of spinal pain (6-
8,12-16). The most commonly performed diagnostic 
interventional techniques include diagnostic facet 
joint nerve blocks, discography, and sacroiliac joint 
injections (6). Based on the controlled evaluations, 
lumbar facet joint pain has been demonstrated in 
15% to 45% of the patients, with a false-positive 
rate of 17% to 50% (17-29), discogenic pain has 
been demonstrated in 26% to 39% (17,30), with a 
significant alleged false-positive rate (31), with a 
prevalence of sacroiliac joint pain in 10% to 26% 
with a false-positive rate of 20% to 22% (17,32,33). 
Similarly in the cervical spine, facet joint pain was 
determined in 36% to 67% of the patients with 
chronic neck pain with a false-positive rate of 27% 
to 63% (18,20,28,34-39) with a reported prevalence 
of cervical discogenic pain in 16% to 20% of the 
patients (39,40). However, while there is no data 
available on the thoracic spine for prevalence of 
discogenic pain (41), facet joints were shown to be 
involved in 34% to 48% of patients with chronic 
thoracic pain with a false-positive rate of 42% to 
58% (18,20,42,43).
There is ongoing controversy regarding the valid-
ity of controlled diagnostic blocks of facet joints. In 
general, precision diagnostic techniques are variable 
in sensitivity, specificity, and accuracy. Thus, identifica-
tion of false-positive rates, false-negative rates, and 
placebo responses is crucial. Numerous reasons have 
been described for false-positive responses to diag-
nostic anesthetic blocks, including placebo response 
to diagnostic injections, use of sedation, liberal use 
of superficial local anesthetic, and the spread of in-
jectate to pain generating structures other than those 
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Methods
Literature Search
A literature search included multiple databases in-
cluding PubMed, EMBASE, and databases of multiple 
journals, Cochrane Reviews, systematic and narrative 
reviews, Clinical Trials Registry, cross references, and 
letters to the experts. A search was conducted from 
1966 through November 2008. 
The search terminology included interventional 
techniques, controlled diagnostic blocks, controlled 
comparative local anesthetic blocks, role of sedation 
for diagnostic blocks, role of opioids, role of anxiolyt-
ics, provocation discography, facet or zygapophysial 
joint nerve blocks.
Inclusion Criteria
Inclusion criteria concentrated on clinical rele-
vance with types of studies concentrating on the role 
of sedation, anxiety on the diagnosis of spinal facet, 
discogenic, or sacroiliac joint pain.
Exclusion criteria included abstracts, publications 
in non-peer reviewed journals, technical reports, ex-




Studies were selected if they met inclusion 
criteria.
Data Extraction
Relevant data on methodology and outcomes 
were collected.
Methodologic Quality Assessment
The Agency for Healthcare Research and Quality 
(AHRQ) criteria for diagnostic testing (76) as reported in 
Table 1 were used for methodologic quality assessment. 
Based on the weighted scoring system developed and 
revised by consensus of the Guidelines Committee of 
the American Society of Interventional Pain Physicians 
CRITERION
Weighted  Score 
(points) 
1.   Study Population 15
    •  Subjects similar to populations in which the test would be used and with a similar spectrum of disease
2.   Adequate Description of Test 10
    •  Details of test and its administration sufficient to allow for replication of study
3.  Appropriate Reference Standard 30
    •  Appropriate reference standard (gold standard) used for comparison 15
    •  Reference standard reproducible 15
4.   Blinded Comparison of Test 30
    •  Evaluation of test without knowledge of disease status, if possible 15
    •  Independent, blind interpretation of test and reference 15
5.   Avoidance of Verification Bias 15
    •  Decision to perform reference standard not dependent on results of test under study
TOTAL SCORE 100
Table 1. Modified AHRQ methodologic assessment criteria for diagnostic interventions. 
Adapted and modified from West et al. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology Assessment No. 47. 
AHRQ Publication No. 02-E016 (76).
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(ASIPP) (12), a total of 100 total points may be award-
ed for each study. This system has been employed in 
other systematic reviews (41,42). Only studies scoring 
50 or above were used in the analysis. Each study was 
scored independently by 2 reviewers. Any discrepancies 
or conflicts were arbitrated by a third author to reach 
a consensus agreement. Any disagreement among the 
reviewers was resolved by discussion and consensus. If 
there was a conflict of interest with the reviewed man-
uscript with authorship or any other type of conflict, 
the involved authors did not review the manuscript for 
quality assessment or evidence synthesis.
Qualitative Analysis of Evidence
Qualitative analysis was conducted using 5 levels 
of evidence, ranging from Level I to III with 3 subcat-




Figure 1 illustrates the search results. The search 
yielded 107 articles for review, of these, only 6 were 
relevant to the study question, with 2 studies evaluat-
ing role of sedation for non-specific intervention tech-
niques (78,79), and 4 studies evaluating the role of 
sedation for diagnostic interventional techniques (71-
74). Methodologic quality assessment of the 6 relevant 
studies (71-73) met the inclusion criteria for methodo-
logic quality assessment. Two studies (78,79) were not 
included as they were not related specifically to diag-
nostic interventions and also the role of sedation and 
its influence on diagnostic value and validity was not 
evaluated. Further, one study (74) was the evaluation 
of the role of placebo and nocebo effects of periop-
erative administration of sedatives and opioids in in-
terventional pain management on the data obtained 
from the previous controlled studies (71-73). 
Table 3 illustrates the methodologic quality as-
sessment of studies evaluating the effect of sedation. 
There were no studies available evaluating the influ-
ence of sedation on diagnostic value or validity of ei-
ther discogenic pain or sacroiliac joint pain.
Study Methods
In 2 studies (71,72), there were 60 patients in each 
group. In the third study (73) there were 20 patients 
in each group. Each patient, based on the randomiza-
tion, received 1 of the 3 solutions in incremental doses 
of 1 mL with a maximum of 5 mL in all groups; 5 mL of 
NaCl in Group I, 1 mg of midazolam per mL (5 mg per 
5 mL) in Group II, or 50 mcg of fentanyl per mL (250 
mcg per 5 mL) in Group III. Patient and investigator 
were blinded to the allocation sequence, as well as the 
solution administered, in all cases. The solutions were 
administered slowly based on the patient’s response 
with relaxation and/or a feeling of drowsiness or until 
the entire syringe of 5 mL was administered. Once the 
patients expressed either drowsiness or relaxation or 
the maximum dose was administered, assessment of 
pain on a numeric pain scale and the ability to perform 
pre-sedation painful movements were reassessed. Af-
ter completion of the evaluation, unblinding was car-
ried out and the amount of sedation administered in 
Groups II and III were noted on the record.
Outcomes Assessment
In all studies, the outcomes were assessed at 
baseline prior to the administration of the solution 
and after the administration of the solution. Multi-
ple parameters included numeric pain scale, percent 
of pain relief, and ability to perform prior painful 
movements.
Table 2. Modified quality of  evidence developed by AHRQ.
I: Evidence obtained from at least one properly randomized controlled trial or multiple well-conducted diagnostic studies
II-1: Evidence obtained from well-designed controlled trials without randomization or at least one well-controlled diagnostic study of  adequate size
II-2: Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group or evidence obtained from at least one properly designed small diagnostic accuracy study
II-3: Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of  the introduction of  penicillin treatment in the 1940s) could also be regarded as this type of  evidence
III: Opinions of  respected authorities, based on clinical experience descriptive studies and case reports or reports of  expert committees
Adapted from the U.S. Preventive Services Task Force (USPSTF) (77).
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Fig. 1. The flow diagram of  the selection process of  the literature.













Manuscripts considered for inclusion:
Original studies
n = 6
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Descriptive Characteristics
Descriptive characteristics of these 3 studies are in-
cluded in Table 4. All 3 studies (71-73) were performed 
by the same group utilizing the same methodology. 
Manchikanti et al (71) performed a randomized, pla-
cebo-controlled, double-blind study and demonstrat-
ed that 2% of the patients in Group I (placebo group 
– NaCl solution), 5% in Group II (midazolam group), 
and 7% in Group III (fentanyl group) had experienced 
≥ 80% pain relief and were able to perform baseline 
painful movements in the post follow-up period in 
patients with chronic low back pain of lumbar facet 
joint origin. Further, evaluation of significant relief of 
≥ 50% relief with ability to perform baseline painful 
movements in the post follow-up period was seen in 
7%, 5%, and 13% of the patients in Groups I, II, and III. 
Significant differences were only noted with regards 
to the relaxation status with 40% in Group I, 93% in 
Group II, and 87% in Group III. This study showed no 
significant differences between the pain relief and 
ability to perform painful movements in any of the 
groups. 
Manchikanti et al (72) performed a randomized, 
prospective, double-blind, placebo-controlled evalua-
tion on the effect of sedation in the diagnostic validity 
of cervical facet joint pain. Pain relief of ≥ 80% was 
noted in 5% of the patients in Group I, 8% in Group II, 
and 8% in Group III. However, pain relief of ≥ 50% was 
noted in 8% of the patients in Group I, 13% in Group 
II, and 27% in Group II. (72). 
In the study by Manchikanti et al (73), 50% to 
100% of the patients reported relaxation, and as 
many as 10% of the patients experienced significant 
pain relief (80% or greater) and were able to perform 
movements that were painful prior to the administra-
tion of intravenous sodium chloride, midazolam, or 
fentanyl. There were no significant differences noted 
either among the groups or between regions (cervical 
vs. lumbar). Significant differences were noted only 
with regards to relaxation status, with 50% reported 
in Group I and 100% in Groups II and III. Thus, overall 
this study showed no significant differences in any of 
the groups between pain relief or the ability to per-
form painful movements and the type of sedation.
Based on the results of a randomized, placebo-
controlled evaluation, 13% to 30% of all the patients 
receiving either sodium chloride solution, midazolam, 
or fentanyl reported a placebo response (74). A small 
proportion (3% to 8%) of patients also reported a 
nocebo response, where they felt worse. The major-
ity of the patients (67% to 79%) described no signifi-
cant change from their previous experience. It is con-
Table 3. Methodologic quality assessment and scoring
( ) weighted item score
Methodological criteria and scoring adapted from West et al. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology 
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of  test and 
reference
(15)
Manchikanti et al 
2004 (72) 15 0 __ 15 __ 15 15 70
Manchikanti et al 
2004  (71) 15 0 __ 15 __ 15 15 70
Manchikanti et al 
2006 (73) 15 0 __ 15 __ 15 15 70
www.painphysicianjournal.com  201
Sedation for Interventional Techniques
cluded that sodium chloride, midazolam, and fentanyl 
are capable of producing placebo, as well as nocebo, 
responses in patients undergoing interventional pro-
cedures. In designing research and interpreting out-
comes, placebo and nocebo effects must be taken into 
consideration.
In all the studies (71-73), Manchikanti et al con-
cluded that prudent administration of intravenous 
preoperative sedative dose of a narcotic such as fen-
tanyl or an anxiolytic such as midazolam is no more 
likely to cause a small proportion of patients to report 
false-positive pain relief with active motion testing 
than sodium chloride placebo. These studies suggest-
ed that the prudent administration of midazolam and 
fentanyl to patients who are not relaxed may not have 
any significant adverse effect on the diagnostic valid-
Table 4. Descriptive characteristics of  sedation for interventional techniques.
Study/Methods Participants Intervention(s) Outcome(s) Result(s) Conclusion(s)









into 3 equal groups 
(60/group); titration 
of agent 1 mL at 
a time; relaxed or 
5 mL max given. 
Group I – NaCl
Group II 
– midazolam








Pain relief of > 80% 
was noted in 5% of the 
patients in Group I, 8% 
in Group II, and 8% in 
Group III. However, > 
50% relief was noted 
in 8% of the patients 
in Group I, 13% of the 
patients in Group II, 
and 27% of the patients 
in Group III. Overall, 
8% of the patients in 
Group I, 13% in Group 
II, and 27% in Group 
III were able to perform 
movements which were 
painful prior to injection.
The administration of sedation 
with midazolam or fentanyl is a 
confounding factor in the diagnosis 
of cervical facet joint pain in 
patients with chronic neck pain. 
However, if > 80% pain relief 
with the ability to perform prior 
painful movements is used as the 
standard for evaluating the effect of 
controlled local anesthetic blocks, 
the diagnostic validity of cervical 
facet joint nerve blocks may be 
preserved.









into 3 equal groups 
(60/group); titration 
of agent 1 mL at a 
time; relaxed or 5 
mL max given 
Group I – NaCl 
Group II 
– midazolam








Pain relief of > 80% 
was noted in 2% of the 
patients in Group I, 5% 
of the patients in Group 
II, and 7% in Group 
III. Pain relief of > 50% 
was noted in 7% of the 
patients in Group I, 5% of 
the patients in Group II, 
and 13% of the patients 
in Group III. There were 
no significant differences 
among the groups.
The administration of sedation 
with midazolam or fentanyl is a 
confounding factor in the diagnosis 
of lumbar facet joint pain in 
patients with chronic low back 
pain. However, this study suggests 
that if strict criteria including pain 
relief and the ability to perform 
prior painful movements is used 
as the standard for evaluating the 
effect of controlled local anesthetic 
blocks, the diagnostic validity of 
lumbar facet joint nerve blocks may 
be preserved. 












into 3 equal groups 
(20/group); titration 
of agent 1 mL at a 
time; relaxed or 5 
mL max given 
Group I – NaCl 
Group II 
– midazolam








Overall, 50% of the 
patients were relaxed or 
sedated in the placebo 
group, while 100% 
of the patients in the 
midazolam and fentanyl 
groups were relaxed or 
sedated. As many as 10% 
of the patients reported 
significant relief 
(≥ 80%) with the ability 
to perform prior painful
movements.
Perioperative administration of 
sodium chloride, midazolam, or 
fentanyl can confound results in 
the diagnosis of combined cervical 
and lumbar facet joint pain. False-
positive results with placebo or 
sedation may be seen in a small 
proportion of patients.
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ity of controlled comparative local anesthetic blocks in 
the cervical or lumbar spine. 
Finally, the previous exposure to the study drugs 
has been shown not to have any significant effect on 
the response during diagnostic blockade (75).
Level of Evidence
Based on the 3 studies (71-73) evaluating the in-
fluence of sedation on the diagnostic accuracy in the 
diagnosis of facet joint pain, based on United States 
Preventive Services Task Force (USPSTF) criteria (77), 
as shown in Table 2 criteria, the indicated evidence 
is Level II-1, in the evaluation of cervical and lumbar 
facet joint pain.
discussion
Based on the comprehensive evaluation of all 
the available literature, the lack of influence of se-
dation on controlled facet joint nerve blocks on the 
diagnosis of cervical and lumbar facet joint pain, 
the indicated evidence is Level II-1. All of the stud-
ies showed a lack of influence of sedation either 
with midazolam or even with fentanyl with criterion 
standard of 80% pain relief and the ability to per-
form previously painful movements. The false-posi-
tive results were obtained in 7% of the patients with 
lumbar facet joint nerve blocks in Group III receiving 
fentanyl, whereas it was 8% in patients with cervi-
cal facet joint pain. However, the authors have cau-
tioned that with an application of 50% pain relief as 
the criterion standard, this proportion will increase 
to 13% with lumbar facet joint nerve blocks, whereas 
it would increase to 27% in the cervical group. Based 
on the results of this systematic review it is postu-
lated that appropriate administration of sedation 
either with midazolam or with fentanyl will not ad-
versely affect the diagnostic validity of diagnostic 
facet joint nerve blocks either in the cervical spine or 
lumbar spine. However, 80% pain relief with the abil-
ity to perform previously painful movements should 
be used as a criterion standard. Any other standard 
is not applicable. 
This systematic review showed a significant pauci-
ty of literature and multiple methodological challeng-
es in assessing the influence of sedation on diagnostic 
interventional techniques. We were able to find only 
3 manuscripts (71-73) by the same authors evaluating 
either cervical and/or lumbar facet joint pain. There 
were no studies evaluating provocation discography 
or sacroiliac joint blocks. Further, this evaluation has 
not included patients with combined midazolam and 
fentanyl. Based on the present systematic review, it 
appears that a significant proportion of patients may 
require sedation during the perioperative period of 
diagnostic interventional techniques (78-80).
In fact, Cucuzzella et al (78) performed a survey 
of 500 consecutive patients receiving lumbar, thoracic, 
and/or cervical spinal injections. A 12-item question-
naire assessing patients’ perceived anxiety was admin-
istered before a spinal injection. Subjects were also 
given the questionnaire after their primal injection. 
Percentages requesting sedation for a first and po-
tential second procedure were assessed. Additionally, 
anxiety level and pain rating, location of injection, 
age, sex, and other medication use were analyzed 
to determine the effect on the request for sedation. 
Seventeen percent of patients questioned requested 
sedation before an injection and 28% would request 
sedation if they were to have a second injection. Cu-
cuzzella and colleagues (78) concluded that routine 
sedation before diagnostic and therapeutic injections 
is not necessary as the majority of patients would not 
request sedation before the procedure when given 
the option. However, in some patients sedation is in-
dicated, and many patients may benefit from educa-
tional material on sedation before the injection.
In another study from the same institution, Kim 
et al (79) conducted a study with 301 consecutive spi-
nal injection patients given a choice to take oral or 
IV diazepam, or no sedation before a spinal injection. 
All participating patients filled in a validated anxi-
ety questionnaire before the injection. Patients were 
asked after the injection whether they were satisfied 
with their decision regarding sedation and whether 
their anxiety was controlled effectively. One hundred 
fifty-seven patients (58%) chose to have IV seda-
tion. Of those, 141 (90%) indicated that their anxiety 
was controlled. Eleven (7%) did not think that their 
anxiety was controlled and 5 (3%) did not provide a 
response.
As eluded by Manchikanti and Giordano (80), Kim 
et al (79) showed that 58% of the patients initially 
chose to be sedated and this number increased after 
the first intervention. However, in their previous study 
by Cucuzzella et al (78) only 17% of the patients re-
quested sedation initially reflecting a wide variance. 
Consequently, it is important to consider the differ-
ences in the physical and psychological characteristics 
of patients as seen by interventional physiatrists and 
interventional pain physicians.
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Multiple drugs utilized for anxiolysis and analge-
sia during interventional procedures include benzodi-
azepines, opioids, and other agents (81). Midazolam 
and fentanyl are more frequently used intervenous 
drugs for intraoperative sedation and analgesia due 
to the expected short duration of action combined 
with rapid onset of action. Midazolam is a short-act-
ing benzodiazepine affecting the central nervous sys-
tem depressant activities. The effects of midazolam 
on the central nervous system are dependent on the 
dose administered, the route of administration, and 
the presence or absence of other medications. Clinical 
experience has shown midazolam to be 3 to 4 times as 
potent per mg as diazepam.
Fentanyl is a narcotic analgesic. A dose of 100 
mcg or 0.1 mg or 2 mL is approximately equivalent in 
analgesic activity to 10 mg of morphine or 75 mg of 
meperidine. The principle actions of therapeutic val-
ue are analgesia and sedation. The onset of action of 
fentanyl is almost immediate when the drug is given 
intravenously.
The present evaluation may be criticized for 
several potential drawbacks of the included studies 
(71-73). However, all the studies were placebo-con-
trolled, randomized, double-blind, with 60 patients 
in the smallest group in 3 groups in 2 studies (71,72), 
with appropriate evaluation of outcome parameters 
of pain relief and the ability to perform prior pain-
ful movements. The question about an additional 
group with midazolam and fentanyl may be legiti-
mate. However, administration of the 2 drugs in a 
safe manner would have been extremely difficult, 
specifically limiting the total dosage to 5 mL with 
50% midazolam and 50% fentanyl. The drugs cannot 
be mixed reliably and uniformly. Further, they may 
have to be provided in 2 separate syringes. In such 
a scenario, the study would not be blind. Thus, the 
authors explained that the combined effect of mid-
azolam with fentanyl was not evaluated.
This systematic review utilized stringent criteria for 
inclusion. In the evidence synthesis, we attempted to 
evaluate all types of diagnostic studies, however only 
limited data was available. Further, since the publica-
tion of this literature, Manchikanti et al (75) have il-
lustrated a significant lack of influence of prior expo-
sure on the diagnostic validity of controlled facet joint 
injections. Even then, it is prudent to conduct multiple 
studies not only evaluating the role of sedation in di-
agnosing facet joint pain, but also in the diagnosis of 
discogenic and sacroiliac joint pain and all other types 
of diagnostic interventions. Consequently, the limita-
tions of this manuscript include the paucity of the data 
in general and the lack of availability of data in evalu-
ation of the influence of sedation, with or without opi-
oids, in the diagnosis of discogenic pain and sacroiliac 
joint pain. 
conclusion
This systematic review provides no significant evi-
dence of the influence of sedation either with mid-
azolam or fentanyl in the evaluation of cervical and 
lumbar facet joint pain with controlled cervical and 
lumbar facet joint nerve blocks with indicated evi-
dence of Level II-1. However, the results of this system-
atic review only apply for cervical and lumbar facet 
joint blocks under sedation utilizing the criterion stan-
dard of 80% pain relief with controlled comparative 
local anesthetic blocks with the ability to perform pri-
or painful movements by the patient immediately. 
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